Preben K.
- Country
- Sweden
- Department
- Department of obestretics and gynecology
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Gynecologic Oncology
This investigator specializes in the treatment of epithelial ovarian cancer, with particular emphasis on advanced-stage disease management. Their research explores innovative therapeutic approaches in gynecologic oncology, focusing on the relationship between anticoagulation treatments and cancer biomarkers.
- Advanced Ovarian Cancer Treatment
- Cancer Biomarker Analysis
- Neoadjuvant Therapy Approaches
The investigator's work integrates biomarker monitoring with therapeutic interventions in ovarian cancer treatment.
Cancer Therapeutics
Research interests center on exploring the effects of anticoagulation therapy in cancer treatment, particularly investigating novel applications of established medications in oncology settings. The investigator studies the interaction between blood-thinning agents and cancer progression markers.
- Therapeutic Drug Applications
- Treatment Response Monitoring
- Clinical Biomarker Assessment
Their work examines the impact of therapeutic interventions on cancer-specific markers during treatment.
Clinical Diagnostics
The investigator focuses on diagnostic marker evaluation in gynecologic cancers, particularly studying CA-125 levels as indicators of treatment response. Their research encompasses monitoring disease progression through biomarker analysis.
- Cancer Marker Studies
- Treatment Response Assessment
- Disease Monitoring Protocols
Their expertise includes tracking therapeutic outcomes through systematic biomarker evaluation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.